MedPath

PMS-FLUTICASONE

PMS-FLUTICASONE

Approved
DIN Number

02503166

Drug Class

Human

Market Date

N/A

Company
HC

Pharmascience Inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02503166
AIG Number0124685003
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
R03BA05 FLUTICASONE
Product Specifications
Dosage FormPowder
Route of AdministrationInhalation
AHFS Classification68:04.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

FLUTICASONE PROPIONATEActive
Strength: 250 MCG / ACT
Monograph: FLUTICASONE PROPIONATE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.